M. Zamberlan

485 total citations
21 papers, 347 citations indexed

About

M. Zamberlan is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, M. Zamberlan has authored 21 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 6 papers in Cardiology and Cardiovascular Medicine and 6 papers in Epidemiology. Recurrent topics in M. Zamberlan's work include Transplantation: Methods and Outcomes (16 papers), Renal Transplantation Outcomes and Treatments (6 papers) and Mechanical Circulatory Support Devices (6 papers). M. Zamberlan is often cited by papers focused on Transplantation: Methods and Outcomes (16 papers), Renal Transplantation Outcomes and Treatments (6 papers) and Mechanical Circulatory Support Devices (6 papers). M. Zamberlan collaborates with scholars based in United States, United Kingdom and Canada. M. Zamberlan's co-authors include Robert J. Gajarski, Kurt R. Schumacher, David C. Naftel, Dennis C. Crowley, Elizabeth Pruitt, Melissa K. Cousino, James K. Kirklin, Karen King, Kathleen D. Lake and Charles E. Canter and has published in prestigious journals such as Circulation, The American Journal of Cardiology and American Journal of Transplantation.

In The Last Decade

M. Zamberlan

19 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Zamberlan United States 11 248 145 100 95 68 21 347
Sherrie Rodgers United States 10 229 0.9× 107 0.7× 113 1.1× 55 0.6× 40 0.6× 15 387
Yoon Son Ahn United States 10 297 1.2× 130 0.9× 160 1.6× 45 0.5× 29 0.4× 22 433
E. Dean McKenzie United States 11 167 0.7× 88 0.6× 24 0.2× 87 0.9× 232 3.4× 20 388
Raheel Rizwan United States 11 209 0.8× 114 0.8× 56 0.6× 57 0.6× 86 1.3× 24 273
Franck Laporte France 6 418 1.7× 70 0.5× 179 1.8× 25 0.3× 34 0.5× 8 529
A.P.A. Oomen Netherlands 8 629 2.5× 73 0.5× 300 3.0× 12 0.1× 19 0.3× 10 718
B.T. Oeser United States 7 458 1.8× 188 1.3× 212 2.1× 200 2.1× 32 0.5× 16 517
Gabriel Loor United States 15 464 1.9× 174 1.2× 121 1.2× 99 1.0× 29 0.4× 54 545
Miralem Pasić Germany 10 181 0.7× 20 0.1× 23 0.2× 259 2.7× 113 1.7× 13 377
Joshua Chung United States 11 407 1.6× 255 1.8× 114 1.1× 104 1.1× 32 0.5× 33 504

Countries citing papers authored by M. Zamberlan

Since Specialization
Citations

This map shows the geographic impact of M. Zamberlan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Zamberlan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Zamberlan more than expected).

Fields of papers citing papers by M. Zamberlan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Zamberlan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Zamberlan. The network helps show where M. Zamberlan may publish in the future.

Co-authorship network of co-authors of M. Zamberlan

This figure shows the co-authorship network connecting the top 25 collaborators of M. Zamberlan. A scholar is included among the top collaborators of M. Zamberlan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Zamberlan. M. Zamberlan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cusick, Matthew F., et al.. (2025). Donor-Derived Cell-Free DNA as a Biomarker for the Effect of Daratumumab in Patients with Antibody-Mediated Rejection Post-Heart Transplant. The Journal of Heart and Lung Transplantation. 44(4). S262–S262.
2.
Peng, David M., et al.. (2024). Favorable Response to Daratumumab in the Treatment of Antibody Mediated Rejection in Pediatric Heart Transplant. The Journal of Heart and Lung Transplantation. 43(4). S537–S537.
3.
Schumacher, Kurt R., M. Zamberlan, Karen Uzark, et al.. (2019). Generalized and specific anxiety in adolescents following heart transplant. Pediatric Transplantation. 24(1). e13647–e13647. 20 indexed citations
4.
Cousino, Melissa K., Kurt R. Schumacher, Kelly E. Rea, et al.. (2018). Psychosocial functioning in pediatric heart transplant recipients and their families. Pediatric Transplantation. 22(2). 33 indexed citations
5.
Cousino, Melissa K., et al.. (2017). Variability in Tacrolimus Levels Is Associated with Biopsy Proven Rejection in Pediatric Heart Transplant Recipients. The Journal of Heart and Lung Transplantation. 36(4). S272–S272. 1 indexed citations
6.
Cousino, Melissa K., Kelly E. Rea, M. Zamberlan, et al.. (2017). Psychosocial Screening in Pediatric Heart Transplant Recipients and Their Families. The Journal of Heart and Lung Transplantation. 36(4). S355–S355. 1 indexed citations
7.
Lu, Jimmy C., Sunkyung Yu, Ray Lowery, et al.. (2016). Usefulness of Diastolic Strain Measurements in Predicting Elevated Left Ventricular Filling Pressure and Risk of Rejection or Coronary Artery Vasculopathy in Pediatric Heart Transplant Recipients. The American Journal of Cardiology. 117(9). 1533–1538. 16 indexed citations
8.
Schumacher, Kurt R., Jeffrey G. Gossett, Kristine J. Guleserian, et al.. (2015). Fontan-associated protein-losing enteropathy and heart transplant: A Pediatric Heart Transplant Study analysis. The Journal of Heart and Lung Transplantation. 34(9). 1169–1176. 36 indexed citations
9.
Schumacher, Kurt R., Christopher S. Almond, Tajinder P. Singh, et al.. (2015). Predicting Graft Loss by 1 Year in Pediatric Heart Transplantation Candidates. Circulation. 131(10). 890–898. 51 indexed citations
10.
Friedland‐Little, Joshua, Robert J. Gajarski, Sunkyung Yu, et al.. (2014). Outcomes of third heart transplants in pediatric and young adult patients: Analysis of the United Network for Organ Sharing database. The Journal of Heart and Lung Transplantation. 33(9). 917–923. 3 indexed citations
11.
Aiyagari, Ranjit, et al.. (2014). Left Atrial Deformation Predicts Pulmonary Capillary Wedge Pressure in Pediatric Heart Transplant Recipients. Echocardiography. 32(3). 535–540. 15 indexed citations
12.
Yu, Shan‐Huey, et al.. (2014). Clinical Significance of Anti-HLA Antibodies Associated With Ventricular Assist Device Use in Pediatric Patients: A United Network for Organ Sharing Database Analysis. The Journal of Heart and Lung Transplantation. 33(4). S302–S302. 3 indexed citations
13.
Schumacher, Kurt R., David C. Naftel, Margaret Tresler, et al.. (2012). 24 Predicting 1-Year Survival in Pediatric Heart Transplant Candidates with Cardiomyopathy: An Analysis of the PHTS Database. The Journal of Heart and Lung Transplantation. 31(4). S17–S17. 1 indexed citations
14.
Aiyagari, Ranjit, James G. Gurney, Janet E. Donohue, et al.. (2011). Association of Pediatric Heart Transplant Coronary Vasculopathy with Abnormal Hemodynamic Measures. Congenital Heart Disease. 6(2). 128–133. 10 indexed citations
15.
Gajarski, Robert J., Elizabeth D. Blume, Simon Urschel, et al.. (2010). Infection and malignancy after pediatric heart transplantation: The role of induction therapy. The Journal of Heart and Lung Transplantation. 30(3). 299–308. 38 indexed citations
16.
Uzark, Karen, et al.. (2010). 80: Quality of Life and Predictors of Medication Adherence in Pediatric Heart Transplant Recipients. The Journal of Heart and Lung Transplantation. 29(2). S32–S33. 1 indexed citations
17.
Gajarski, Robert J., Elizabeth D. Blume, Kenneth B. Schechtman, et al.. (2010). 199: Use of Induction Agents and Incidence of Infection and Malignancy Following Pediatric Heart Transplantation. The Journal of Heart and Lung Transplantation. 29(2). S70–S70. 1 indexed citations
18.
Smith, Doug, et al.. (2009). HLA Sensitization in Pediatric Pre-transplant Cardiac Patients Supported by Mechanical Assist Devices: the Utility of Luminex. The Journal of Heart and Lung Transplantation. 28(2). 123–129. 46 indexed citations
19.
Gajarski, Robert J., David C. Naftel, Elfriede Pahl, et al.. (2009). Outcomes of Pediatric Patients With Hypertrophic Cardiomyopathy Listed for Transplant. The Journal of Heart and Lung Transplantation. 28(12). 1329–1334. 38 indexed citations
20.
Gajarski, Robert J., Dennis C. Crowley, M. Zamberlan, & Kathleen D. Lake. (2004). Lack of Correlation Between MMF Dose and MPA Level in Pediatric and Young Adult Cardiac Transplant Patients: Does the MPA Level Matter?. American Journal of Transplantation. 4(9). 1495–1500. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sherrie Rodgers Breakdown of academic impact, for papers by Yoon Son Ahn Breakdown of academic impact, for papers by E. Dean McKenzie Breakdown of academic impact, for papers by Raheel Rizwan Breakdown of academic impact, for papers by Franck Laporte Breakdown of academic impact, for papers by A.P.A. Oomen Breakdown of academic impact, for papers by B.T. Oeser Breakdown of academic impact, for papers by Gabriel Loor Breakdown of academic impact, for papers by Miralem Pasić Breakdown of academic impact, for papers by Joshua Chung
Rankless by CCL
2026